NCT07557550

Brief Summary

In adults, the prevalence of preoperative anxiety related to surgery or anesthesia ranges from 60 to 80%, and context plays an important role. Patients with significant preoperative anxiety experience reduced sleep quality. In addition, high preoperative anxiety is linked to more severe postoperative pain and an increased need for painkillers. In addition, it is a source of dysfunction in care. Currently, there are no recommendations regarding the prevention of preoperative anxiety. New approaches have emerged that show some benefit: music, binaural auditory stimulation and hypnosis. In the UAC J0 unit of the Amiens-Picardie University Hospital, the caregivers offer the PSiO glasses, a tool combining three techniques: light therapy, relaxation and chromotherapy. This system has obtained CE and FCC markings and seems to be more or less effective on patients admitted to the CH . A pilot study evaluating the effects of virtual reality hypnosis on patients' preoperative anxiety has shown that this technology represents a non-invasive way to reduce preoperative stress levels without side effects and without the need for additional medical or paramedical staff. This study aims to improve the patient's well-being before their operation. Depending on the randomization, he will benefit from a relaxation session with the Psio glasses or a virtual reality hypnosis session with the Hypno VR headset. Follow-up of patients will be carried out on the basis of variation in an anxiety scale, physiological criteria, the amount of anesthetic products used, the time spent in the recovery room, and the evaluation of pain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
632

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Apr 2026Apr 2027

Study Start

First participant enrolled

April 1, 2026

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 23, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 23, 2026

Last Update Submit

April 23, 2026

Conditions

Keywords

relaxationvirtual realityanxiety preoperative

Outcome Measures

Primary Outcomes (1)

  • Variation in the score on the APAIS anxiety scale

    Variation in the score on the APAIS scale, 6-item scale rated from 1 to 5 The anxiety score sums items 1, 2, 4 and 5 (\>11 = anxious subjects) The information desire score sums items 3 and 6 (2 to 4 = refusal of information, 5 to 7 = average desire for information, \>7 = eager desire for information)

    1 hour

Secondary Outcomes (7)

  • Heart rate variation

    1 hour

  • Variation in respiratory rate

    over 1 minute

  • Blood pressure variation

    1 hour

  • Variation in oxygen saturation

    1 hour

  • Quantity of product used

    1 hour

  • +2 more secondary outcomes

Study Arms (3)

HypnoVR group

EXPERIMENTAL

The patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.

Device: HypnoVR

PSIO Group

EXPERIMENTAL

the patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.

Device: PSIO

Group without relaxation tool

SHAM COMPARATOR

the patient will wait 20-minute, without benefit of sendorial tools.

Device: no relaxation tool

Interventions

PSIODEVICE

the patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.

PSIO Group
HypnoVRDEVICE

The patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.

HypnoVR group

Group without relaxation tool: the patient will wait 20-minute, without benefit of sendorial tools.

Group without relaxation tool

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient treated at the UAC D0
  • Orthopedic patient (arthroplasty mainly)
  • Anesthesic procedure with general anesthesia
  • Patient \>18 years old without cognitive impairment in the investigator's judgment
  • Patient who has signed a free and informed consent
  • Patient affiliated to a social security scheme

You may not qualify if:

  • Patient with deafness that does not allow him to perceive and understand sounds
  • Patient with a visual impairment who does not allow him to watch and understand a video
  • Patient who does not master the French language (spoken, written and read)
  • Patient with a history of epilepsy
  • Patient with a history of migraine/headache when using a virtual reality headset
  • Patients with a history of dizziness triggered by images (film, video game...)
  • Patient with untreated dry eye disease
  • Patient with psychiatric diseases and disorders not compatible with the study in the investigator's judgment
  • Patient who is pregnant, parturient, or breastfeeding.
  • Patient under guardianship or curatorship, under judicial protection or deprived of public law

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amiens University Hospital

Amiens, Picardie, 80054, France

RECRUITING

Central Study Contacts

François JOACHIM, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2026

First Posted

April 29, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations